Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Microneedling is a safe and effective way to improve various skin conditions with minimal side effects.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Angio PRP speeds up skin wound healing and reduces inflammation.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.